News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases
Shankar Siva/iconcancercentre.com.au
May 11, 2025, 15:32

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

” New in Journal of Clinical Oncology – ROBOMET
SABR vs standard radiotherapy for painful bone mets.
  • Pain relief at 1 month:
  • SABR (20 Gy single dose): 37% complete response
  • versus (8 Gy): 25% complete response
  • at 3-months withSABR: 54% vs 31%, p= .048″

Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

Authors: Carole Mercier, Charlotte Billiet, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix

You can read the Full Article on Journal of Clinical Oncology

Shankar Siva

More posts featuring Shankar Siva.

bone metastases cancer Carole Mercier Charlotte Billiet Conventional Radiotherapy Dirk Verellen Geert De Kerf Journal of Clinical Oncology Katrien Vandecasteele Luc Dirix Michaël Claessens OncoDaily Oncology Peter Vermeulen Piet Dirix radiotherapy ROBOMET Shankar Siva Stereotactic Radiotherapy Steven Van Laere Yolande Lievens
Special Coverage
Drugs
Jul 10, 2025, 01:19
Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions
Blog
Jul 9, 2025, 23:49
Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer 
Insight
Jul 9, 2025, 23:06
Steven Rosenberg: The beginning of a new way to use immunotherapy
Blog
Jul 9, 2025, 22:10
Roland Busch: The busier the schedule, the more important the workout and discipline becomes
Blog
Jul 9, 2025, 21:45
Pierre Foidart: Honored to Receive Clinical Research Mandate from Stichting tegen Kanker - Fondation contre le Cancer
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Blog
Jul 9, 2025, 21:13
Asfand Yar Cheema: Calling All Internal Medicine Residents
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience
Blog
Jul 9, 2025, 20:27
Upcoming Global Cancer Research and Control Seminar Series - NCI Center for Global Health
Blog
Jul 9, 2025, 20:16
Rob Winn: Join for the Closing the Gap Cancer Summit